GB1227691A
Expires 1971-04-07 · 55y expired
What this patent protects
1,227,691. 1 - Glycosyl - 5 - azacytosines. CESKOSLOVENSKA AKADEMIE VED. 24 April, 1969 [8 May, 1968], No. 21132/69. Heading C2C. 1-Glycosyl-5-azacytosines of the general formula wherein R1 is a glycosyl residue, R<SP>2</SP> is a hydrogen atom or a C 1-4 alkyl group …
USPTO Abstract
1,227,691. 1 - Glycosyl - 5 - azacytosines. CESKOSLOVENSKA AKADEMIE VED. 24 April, 1969 [8 May, 1968], No. 21132/69. Heading C2C. 1-Glycosyl-5-azacytosines of the general formula wherein R1 is a glycosyl residue, R<SP>2</SP> is a hydrogen atom or a C 1-4 alkyl group and R<SP>3</SP> and R<SP>4</SP>, which are the same or different, are each a hydrogen atom, a C 1-4 alkyl group or a C 7-10 aralkyl group, are prepared by reaction of a 1- peracylglycosyl - 1,2 - dihydro - 1,3,5 - triazin- 2-one of the general formula wherein R<SP>5</SP> is a peracylglycosyl residue, the acyl group containing from 2 to 10 carbon atoms, and X is a C 1-4 alkoxy or alkylthio group, with an alkali metal C 1-6 alkoxide and treatment of the resulting 1 -glycosyl- 1 ,2-dihydro - 4 - alkoxy - 1,3,5 - triazin - 2 - one of the general formula wherein R<SP>6</SP> is a C 1-6 alkyl group, with ammonia or an amine of the general formula R<SP>3</SP>R<SP>4</SP>NH. The two steps may be carried out simultaneously using the ammonia or amine in the form of an alkanol solution thereof, or the first step may be omitted.
Drugs covered by this patent
- Vidaza (azacitidine) · Bristol-Myers Squibb
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.